Fosun Pharma is a pharmaceutical company.
Fosun Pharma, founded in May, 1995 and headquartered in Shanghai, is a pharmaceutical distribution, retail and medical service company. The founders are Chen Qiyu and Yao Fang. Listed on the HKEX on October 30, 2012, the company's major shareholders are Shanghai Fosun High Technology (Group) Co., Ltd., HKSCC Nominees Ltd and Hong Kong Securities Clearing Co., Ltd. Rivals that have direct and indirect competition with Fosun Pharma include 111 Group, JD health, Glaxo Smith Kline, Pfizer, etc.
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
ResearchConsumer Staples, Healthcare, Technology
WIA2020 | Rising Tech Stars 2020: Global & China's 100
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM